Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Courtney Fuller"'
Publikováno v:
Personalized medicine. 9(7)
Personalized medicine is rapidly developing a purposeful niche in the field of oncology. Monitoring the activity of the oncogenic fusion gene BCR–ABL1 in chronic myeloid leukemia (CML) is a good example of individualizing CML treatment for patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac117096942e33fe39a08600939cda54
https://pubmed.ncbi.nlm.nih.gov/29776270
https://pubmed.ncbi.nlm.nih.gov/29776270
Autor:
Mehmet Sitki Copur, Ryan Ramaekers, Mithat Gönen, Mary Gulzow, Rebecca Hadenfeldt, Courtney Fuller, Jenifer Scott, Sarah Einspahr, Heather Benzel, Mary Mickey, Max Norvell, Douglas Clark, Dron Gauchan, Dax Kurbegov
Publikováno v:
Journal of oncology practice. 12(1)
QUESTION ASKED: What is the impact of participating in the National Cancer Institute Community Cancer Centers Program (NCCCP) on the number of clinical trials available, number of patients enrolled in trials, and trial-related services provided to pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6fc19ace94cf150b64061875a2ff388
https://pubmed.ncbi.nlm.nih.gov/27621335
https://pubmed.ncbi.nlm.nih.gov/27621335
Autor:
Ryan Ramaekers, Yuzhen Zhou, Christine Johnson, David Crockett, Alexis Woodward, Max Norvell, Courtney Fuller, Dron Gauchan, Rhonda Evans, Douglas Clark, Adriene Tasa, Megan Schriner, Monica McDonald, Darla Cleveland, Mehmet Sitki Copur, Rebecca Hadenfeldt, Vicki Hurley, Jami Kezeor, M. Mickey
Publikováno v:
Journal of Clinical Oncology. 35:e18040-e18040
e18040 Background: Patient navigation is an intervention to improve cancer outcomes by facilitating timely access to cancer care. Few comparative data exist about the effects of nurse navigation in core navigation metrics (CNM) in a community oncolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::498dc38ed58ce59d4bbc997f440e76e4
https://doi.org/10.1200/jco.2017.35.15_suppl.e18040
https://doi.org/10.1200/jco.2017.35.15_suppl.e18040
Autor:
H. Benzel, Mark Tharnish, Jon Olsen, Courtney Fuller, Rebecca Hadenfeldt, Ryan C. Ramaekers, Mehmet Sitki Copur, Angela Mae Obermiller, Melhem Salim Jabbour, Deborah Nelson, Rita Hays, Megan Schriner
Publikováno v:
Journal of Clinical Oncology. 30:9110-9110
9110 Background: Pegfilgrastim reduces neutropenia risk in patients (pts) on cytotoxic chemotherapy. A single 6 mg dose per chemotherapy cycle commonly causes bone pain and leukocytosis. While half-dose pegfilgrastim has been shown to be safe and eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94545fed3922c99650a486303c0a9384
https://doi.org/10.1200/jco.2012.30.15_suppl.9110
https://doi.org/10.1200/jco.2012.30.15_suppl.9110
Autor:
Jason R. Morich, Chad D. Galderisi, Emmanuel Beillard, Michael Heinrich, Courtney Fuller, Brian J. Druker
Publikováno v:
Blood. 108:2334-2334
Mutations in the kinase domain of BCR-ABL result in impaired drug binding and are thought to be the leading cause of acquired resistance to the tyrosine kinase inhibitor imatinib (Gleevec®). While imatinib is a highly effective therapy in all stages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a49e23b854c4eb68113f20b1cb205435
https://doi.org/10.1182/blood.v108.11.2334.2334
https://doi.org/10.1182/blood.v108.11.2334.2334
Autor:
Timothy P. Hughes, Courtney Fuller, Michael Heinrich, Julie Toplin, Rosemary Mazanet, Chad Galderisi, Brian J. Druker, Emmanuel Beillard, Linda Fletcher, Stephane Wong, Peter Maslak, Jorge E. Cortes, Susan Branford
Publikováno v:
Memorial Sloan Kettering Cancer Center
Introduction: Major Molecular Response (MMR) is defined as a three-log reduction from a standardized baseline of BCR-ABL/control gene transcript ratio in CML patients at diagnosis. MMR has prognostic significance for progression-free survival for pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e92b85596e807c830a5b8e15c3c14b7
https://synapse.mskcc.org/synapse/works/25843
https://synapse.mskcc.org/synapse/works/25843
